351 related articles for article (PubMed ID: 8616725)
1. What have clinical trials taught us about proarrhythmia?
Skanes AC; Green MS
Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
[TBL] [Abstract][Full Text] [Related]
2. [The pro-arrhythmic effects of anti-arrhythmia agents].
Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
[TBL] [Abstract][Full Text] [Related]
3. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
4. [Mishaps with anti-arrhythmic agents used to reduce mortality after infarction].
Funck-Brentano C
Rev Prat; 1992 Nov; 42(17):2175-8. PubMed ID: 1290040
[TBL] [Abstract][Full Text] [Related]
5. Is there a need for new antiarrhythmic drugs?
Roden DM
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
[TBL] [Abstract][Full Text] [Related]
6. [What is the latest in anti-arrhythmia therapy?].
Gloor HO
Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
[TBL] [Abstract][Full Text] [Related]
7. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
Lazzara R
Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
[TBL] [Abstract][Full Text] [Related]
8. Assessment of arrhythmias after myocardial infarction in the post-CAST era.
Camm AJ; Kautzner J
Can J Cardiol; 1996 Apr; 12 Suppl B():9B-19B; discussion 27B-28B. PubMed ID: 8616727
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
Gambhir DS
Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
[No Abstract] [Full Text] [Related]
10. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
Shah SA; Kluger J; White CM
Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
[TBL] [Abstract][Full Text] [Related]
11. Class III antiarrhythmic agents: the next wave.
Bauman JL
Pharmacotherapy; 1997; 17(2 Pt 2):76S-83S; discussion 89S-91S. PubMed ID: 9085343
[TBL] [Abstract][Full Text] [Related]
12. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
Scholz H
Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
[TBL] [Abstract][Full Text] [Related]
13. [Management of patients with risk of sudden death. The amiodarone example].
Djian J
Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868
[TBL] [Abstract][Full Text] [Related]
14. [Proarrhythmia caused by amiodarone].
Pagano L; Della Monica R; Malinconico M
Minerva Cardioangiol; 2001 Dec; 49(6):421-8. PubMed ID: 11733739
[TBL] [Abstract][Full Text] [Related]
15. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
Makai A; Rudas L; Liszkai G; Fazekas T
Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
[TBL] [Abstract][Full Text] [Related]
16. Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management.
Hohnloser SH
Am J Cardiol; 1997 Oct; 80(8A):82G-89G. PubMed ID: 9354415
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of amiodarone.
Nolan PE; Nappi J; Pollak PT
Pharmacotherapy; 1998; 18(6 Pt 2):127S-137S. PubMed ID: 9855345
[TBL] [Abstract][Full Text] [Related]
18. A critical appraisal of the cardiac arrhythmia suppression trial (CAST).
Naccarelli GV; Dougherty AH; Wolbrette D; Wiggins S
Appl Cardiopulm Pathophysiol; 1991; 4(1):9-16. PubMed ID: 10147539
[TBL] [Abstract][Full Text] [Related]
19. Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone.
Smetana P; Pueyo E; Hnatkova K; Batchvarov V; Laguna P; Malik M
J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1147-54. PubMed ID: 15485438
[TBL] [Abstract][Full Text] [Related]
20. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
Arós Borau F; Loma-Osorio A; Torres Bosco A
Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]